Sunitinib is a drug that inhibits multiple proteins in cancer cells, thus limiting their growth and division. It has been already used in treating advanced renal cell cancer and two other forms of malignancy. In the new phase-2 trial conducted by the Med Start Washington Hospital Center (Washington, D.C.), the treatment proved to be efficient […]
Home » sunitinib